Jiksak Bioengineering
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $3.4M
Investors
- 4
About Jiksak Bioengineering
Based in Kawasaki, Japan, Jiksak Bioengineering Inc.Jiksak Bioengineering Inc. is focused on developing advanced therapeutic solutions for neurological disorders. Founded in 2017 in Kawasaki, Japan, the company has completed a total of 4 deals.802 million.Jiksak Bioengineering, Inc. focuses on advanced biotechnological solutions aimed at addressing intractable neurological diseases. Central to its offerings is the Nerve Organoid™ technology, which facilitates the development of safer nerve conduits that enhance the efficacy of peripheral nerve regeneration and functional restoration. These products are designed to specifically target conditions such as amyotrophic lateral sclerosis (ALS) and other neuromuscular diseases by utilizing proprietary molecules that interact at the neuromuscular junction. The company’s client base primarily includes healthcare institutions, research facilities, and potentially pharmaceutical companies that seek innovative therapies for neurological disorders.Jiksak Bioengineering generates revenue through the commercialization of its proprietary technologies and therapeutic solutions, structured primarily as B2B transactions. The company partners with medical research institutions and hospitals to deliver its flagship products, such as those developed under the Nerve Organoid™ brand. These transactions may take the form of direct sales agreements or collaborative partnerships for research and product development. Pricing structures for these services are established on a contractual basis, tailored to the specific needs of each partner, and are designed to reflect the advanced nature and efficacy of the technologies offered. The focus will be on introducing new products aimed at treating neurological disorders, with specific timelines for market entry yet to be disclosed. In addition to enhancing its product line, Jiksak aims to expand its operations into new markets, specifically targeting North America and Western Europe by the end of 2023.
Who invested in Jiksak Bioengineering
4 investors across 1 round
See all investors in Jiksak Bioengineering
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 29, 2022
Amount
$3.4M
Investors
Questions about Jiksak Bioengineering
Who invested in Jiksak Bioengineering?
Jiksak Bioengineering has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiksak Bioengineering raised?
Jiksak Bioengineering has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Jiksak Bioengineering last raise money?
Jiksak Bioengineering's most recent round on record is a Series B, in Aug 2022.
What does Jiksak Bioengineering do?
Based in Kawasaki, Japan, Jiksak Bioengineering Inc.
Where is Jiksak Bioengineering headquartered?
Jiksak Bioengineering is headquartered in Kawasaki, Japan.
Which VCs invest in companies like Jiksak Bioengineering?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Jiksak Bioengineering's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Jiksak Bioengineering? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.